Terms: = Colorectal cancer AND CD79B, ENSG00000007312, 974, P40259, IGB, B29 AND Treatment
38 results:
1. Preoperative prediction of perineural invasion of rectal cancer based on a magnetic resonance imaging radiomics model: A dual-center study.
Liu Y; Sun BJ; Zhang C; Li B; Yu XX; Du Y
World J Gastroenterol; 2024 Apr; 30(16):2233-2248. PubMed ID: 38690027
[TBL] [Abstract] [Full Text] [Related]
2. Identification of Genomic Signatures for colorectal cancer Survival Using Exploratory Data Mining.
Hummel JJ; Liu D; Tallon E; Snyder J; Warren W; Shyu CR; Mitchem J; Cortese R
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542194
[TBL] [Abstract] [Full Text] [Related]
3. Combining pathological risk factors and T, N staging to optimize the assessment for risk stratification and prognostication in low-risk stage III colon cancer.
Xian ZY; Song YW; Zhang ZJ; Gan YG; Chen YL; Hu T; Wen XF; Mo TW; He XW
World J Surg Oncol; 2024 Jan; 22(1):10. PubMed ID: 38178080
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of total tumor volume reduction ratio in initially unresectable colorectal liver metastases after first-line systemic treatment.
He J; Li W; Zhou J; Sun H; Zhou C; Liu Y; Quan T; Fan W; Pan Z; Lin J; Peng J
Eur J Radiol; 2023 Aug; 165():110950. PubMed ID: 37437437
[TBL] [Abstract] [Full Text] [Related]
5. Survival comparison of first-line treatment regimens in patients with braf-mutated advanced colorectal cancer: a multicenter retrospective study.
Meng Q; Zhao J; Yu Y; Wang K; Ren J; Xu C; Wang Y; Wang G
BMC Cancer; 2023 Feb; 23(1):191. PubMed ID: 36849918
[TBL] [Abstract] [Full Text] [Related]
6. RAS Mutation Status Should Not Be Used to Predict Outcome from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for colorectal Peritoneal Metastases.
Bhullar D; O'Dwyer S; Wilson M; Saunders MP; Kochhar R; Barriuso J; Aziz O
Ann Surg Oncol; 2023 Feb; 30(2):792-801. PubMed ID: 36400886
[TBL] [Abstract] [Full Text] [Related]
7. Active breathing control guided stereotactic body ablative radiotherapy for management of liver metastases from colorectal cancer.
Gamsiz H; Sager O; Uysal B; Dincoglan F; Demiral S; Colak O; Ozcan F; Dirican B; Beyzadeoglu M
Acta Gastroenterol Belg; 2022; 85(3):469-475. PubMed ID: 35770280
[TBL] [Abstract] [Full Text] [Related]
8. Genetic variants involved in the cGAS-STING pathway predict outcome in patients with metastatic colorectal cancer: Data from FIRE-3 and TRIBE trials.
Wang J; Xiao Y; Loupakis F; Stintzing S; Yang Y; Arai H; Battaglin F; Kawanishi N; Jayachandran P; Soni S; Zhang W; Mancao C; Cremolini C; Liu T; Heinemann V; Falcone A; Shen L; Millstein J; Lenz HJ
Eur J Cancer; 2022 Sep; 172():22-30. PubMed ID: 35749909
[TBL] [Abstract] [Full Text] [Related]
9. Oncological outcomes of multimodality treatment for patients undergoing surgery for locally recurrent rectal cancer: A systematic review.
Fadel MG; Ahmed M; Malietzis G; Pellino G; Rasheed S; Brown G; Tekkis P; Kontovounisios C
Cancer Treat Rev; 2022 Sep; 109():102419. PubMed ID: 35714574
[TBL] [Abstract] [Full Text] [Related]
10. Endoscopic Stricturotomy for Patients With Postoperative Benign Anastomotic Stricture for colorectal cancer.
Lin D; Liu W; Chen Z; He X; Zheng Z; Lan P; Hu J
Dis Colon Rectum; 2022 Apr; 65(4):590-598. PubMed ID: 34775404
[TBL] [Abstract] [Full Text] [Related]
11. Predictors of clinical outcomes of self-expandable metal stent treatment for malignant colorectal obstruction: A Honam Association for the Study of Intestinal Disease (HASID) multicenter study.
Han B; Hong JY; Myung E; Oh HH; Yang HC; Kim SW; Lee J; Kim SJ; Han YD; Seo GS; Hong GY; Kim HD; Kim HS; Joo YE
Medicine (Baltimore); 2021 Jul; 100(27):e26616. PubMed ID: 34232219
[TBL] [Abstract] [Full Text] [Related]
12. Porcupine inhibitors: Novel and emerging anti-cancer therapeutics targeting the Wnt signaling pathway.
Shah K; Panchal S; Patel B
Pharmacol Res; 2021 May; 167():105532. PubMed ID: 33677106
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic value of metastatic pattern in colorectal cancer: a multicenter retrospective analysis in a real-life cohort.
Rumpold H; Kirchweger P; Niedersüß-Beke D; Falch D; Wundsam H; Metz-Gercek S; Piringer G; Thaler J
Acta Oncol; 2021 Feb; 60(2):180-186. PubMed ID: 33095652
[TBL] [Abstract] [Full Text] [Related]
14. Immunohistochemistry-Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II colorectal cancer.
Li Y; Yao Q; Zhang L; Mo S; Cai S; Huang D; Peng J
Oncologist; 2020 Dec; 25(12):e1968-e1979. PubMed ID: 32926498
[TBL] [Abstract] [Full Text] [Related]
15. Feasibility and Outcome of Routine Use of Concurrent Chemoradiation in HIV-positive Patients With Squamous Cell Anal cancer.
Leiker AJ; Wang CJ; Sanford NN; Aguilera TA; Karri S; Beg MS; Kazmi SA; Olson C; Matthews JA; Abdelnaby A; Meyer JJ; Folkert MR
Am J Clin Oncol; 2020 Oct; 43(10):701-708. PubMed ID: 32694298
[TBL] [Abstract] [Full Text] [Related]
16. Transcatheter rectal arterial chemoembolization with oxaliplatin plus S-1 concurrent chemoradiotherapy can improve the pathological remission rate in locally advanced rectal cancer: a comparative study.
Yang B; Shan J; Feng Y; Dai N; Li M; Chen C; He S; Wang G; Xiao H; Li C; Wang D
Radiat Oncol; 2020 May; 15(1):94. PubMed ID: 32375814
[TBL] [Abstract] [Full Text] [Related]
17. Health-related Quality of Life in the Phase III LUME-Colon 1 Study: Comparison and Interpretation of Results From EORTC QLQ-C30 Analyses.
Lenz HJ; Argiles G; Yoshino T; Lonardi S; Falcone A; Limón ML; Sobrero A; Hastedt C; Peil B; Voss F; Griebsch I; Van Cutsem E
Clin Colorectal Cancer; 2019 Dec; 18(4):269-279.e5. PubMed ID: 31628043
[TBL] [Abstract] [Full Text] [Related]
18. Age at Diagnosis and Sex Are Associated With Long-term Deficits in Disease-Specific Health-Related Quality of Life of Survivors of Colon and Rectal cancer: A Population-Based Study.
Thong MSY; Doege D; Koch-Gallenkamp L; Bertram H; Eberle A; Holleczek B; Waldeyer-Sauerland M; Waldmann A; Zeissig SR; Brenner H; Arndt V
Dis Colon Rectum; 2019 Nov; 62(11):1294-1304. PubMed ID: 31567919
[TBL] [Abstract] [Full Text] [Related]
19. Initial Results of a Multicenter Phase 2 Trial of Stereotactic Ablative Radiation Therapy for Oligometastatic cancer.
Sutera P; Clump DA; Kalash R; D'Ambrosio D; Mihai A; Wang H; Petro DP; Burton SA; Heron DE
Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):116-122. PubMed ID: 30149056
[TBL] [Abstract] [Full Text] [Related]
20. Effectiveness of colorectal cancer Screening in Detecting Earlier-Stage Disease-A Nationwide Cohort Study in Denmark.
Larsen MB; Njor S; Ingeholm P; Andersen B
Gastroenterology; 2018 Jul; 155(1):99-106. PubMed ID: 29626451
[TBL] [Abstract] [Full Text] [Related]
[Next]
